Journal of Cancer Clinical Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Review Article - Journal of Cancer Clinical Research (2021) Volume 4, Issue 1

Review on defensive roles of thymoquinone nanobiosensoring prospective in opposition to cancer.

Thymoquinone (TQ), the most important bioactive constituent of Nigella sativa, has been originating to exhibit anticancer effects in plentiful preclinical studies. Due to its multi targeting character, TQ interferes in an extensive assortment of tumorigenic processes and counteracts carcinogenesis, malicious growth, incursion, exodus, and angiogenesis. Moreover, TQ can exclusively sensitize tumor cells on the way to predictable cancer treatments (e.g., chemotherapy, immunotherapy, and radiotherapy) and at the same time lessen psychoanalysis connected lethal effects in regular cells. In this review, we summarized the adjuvant prospective of TQ as observed in an assortment of in vitro and in vivo animal models and discussed the pharmacological properties of TQ to diminish its additional role in potentiating the usefulness of usual remedial modalities specifically surgery, radiotherapy, chemotherapy, and immunotherapy. On the whole we suggest supplementary ample evaluation of TQ in preclinical and clinical levels to demarcate its obscure usefulness as a novel corresponding adjuvant remedy for cancer treatment. The focal point on nanotechnology for enhanced bioavailability and drug deliverance is of increasing significance for organizing different human diseases. Therefore, copious nanoformulations have been urbanized for the oral bioavailability of different drugs. This appraisal introduces applications of nanomedicine to improve the biological actions of thymoquinone (TQ) to be in charge of dissimilar diseases in more than a few in vivo studies as a beginning analysis for human disease healing with nano-TQ. Nano-TQ successfully augments the anticancer roles of doxorubicin by up principle of P53 and downward guideline of Bcl2 and potentiates paclitaxel’s apoptosis in MCF-7 breast cancer cells. In addition nano-TQ protects in opposition to diabetes, inflammation, CNS, and hepatotoxicity, essentially by enhancement of organs’ antioxidant condition. We sum up the pros and cons of several FDA approved nanoparticle-based therapeutics and talk about the roadblocks in clinical translation, along with probable nano-TQ strategies to conquer these roadblocks. From this assessment we can bring to a close that nano-TQ may be measured as a talented nutraceutical for human being healthiness.

Author(s): A Mohamed Sikkander

Abstract PDF

Get the App